Search results for "antibody therapy"

Slowing the Inevitable: How Early Antibody Therapy Is Transforming Alzheimer’s Care

Slowing the Inevitable: How Early Antibody Therapy Is Transforming Alzheimer’s Care

“Lately, I keep forgetting appointments.” “They keep repeating what they just said.” When memory lapses in a parent become noticeable, families...
Metabolic Syndrome Linked to Precancerous Stomach Lesions Independent of H. pylori

Metabolic Syndrome Linked to Precancerous Stomach Lesions Independent of H. pylori

Patients who receive clear Helicobacter pylori test results during routine health screenings may still face an elevated risk of precancerous stomach...
Blurry Vision and Sudden Limb Weakness Could Signal Multiple Sclerosis, Not Just Stroke

Blurry Vision and Sudden Limb Weakness Could Signal Multiple Sclerosis, Not Just Stroke

When vision suddenly turns cloudy in one eye and an arm or leg feels unexpectedly weak, many patients immediately fear...
VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial

VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial

Otsuka Pharmaceutical’s VOYXACT (active ingredient: sibeprenlimab) demonstrated long-term kidney protection by...
Losing Weight Despite a Big Appetite? Blame Your Thyroid, Not the Summer Heat

Losing Weight Despite a Big Appetite? Blame Your Thyroid, Not the Summer Heat

On scorching summer days, it is easy to blame the weather when you sweat excessively, feel drained, or lie awake at...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

For patients diagnosed with aggressive blood cancers, receiving a proven targeted therapy offers a clear path toward a...
Beyond Seoul: How a Secondary Hospital in Busan Mastered 167 Incompatible Kidney Transplants

Beyond Seoul: How a Secondary Hospital in Busan Mastered 167 Incompatible Kidney Transplants

When a family member steps forward to donate a kidney to a loved one suffering from end-stage renal disease, a blood...
Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production

Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production

GC Green Cross has secured priority access to critical manufacturing consumables to stabilize the production of Alyglo,...
Landmark Biotech Deal: Celltrion Acquires Autoimmune Disease Antibody Tech from Catholic University of Korea

Landmark Biotech Deal: Celltrion Acquires Autoimmune Disease Antibody Tech from Catholic University of Korea

A research team led by Kim Wan-wook at the Catholic University of Korea College of Medicine has successfully...